Rupee breaches 60-mark against the dollar; plunges to new all-time low of 60.35

The rupee plunged by 69 paise to 60.35 a dollar at 1535 hrs on the Inter-Bank Foreign Exchange market today due to increased buying by banks and oil importers

The rupee on Wednesday plunged to an all-time low of 60.35 against the dollar in mid-session trade, dragged down by heavy month-end demand for the US currency.


After a lower start, the rupee plunged by 69 paise to 60.35 a dollar at 1535 hrs on the Inter-Bank Foreign Exchange market today due to increased buying by banks and oil importers, forex dealers said.


Persistent foreign capital outflows from weak local equities also affected the rupee value against the dollar, they said.


The Indian currency also remained under pressure following reports of the dollar continuing its upward march against other leading currencies for the sixth straight day.


The downward trend was fuelled further by data underscoring the US Federal Reserve's view of an improving economy and a likely slowdown in monetary stimulus.


Treasury managers are expecting the RBI to intervene to stem rupee's fall.


Sensex, Nifty’s struggle to stay up fails: Wednesday Closing Report

A close above 5,605 on the Nifty will be the first sign of a reversal of the downturn. A close above 5,675 will be a strong confirmation of the upmove

The range-bound market gave up all its gains in the post-noon session after the rupee touched a new all-time low of 60.35 against the dollar in intraday trade. A close above 5,605 on the Nifty will be the first sign of a reversal of the downturn. A close above 5,675 will be a strong confirmation of the upmove. The National Stock Exchange (NSE) registered a volume of 57.13 crore shares and advance-decline ratio of 498:894.


The Indian market opened in the positive following the market regulator Securities and Exchange Board of India’s (SEBI) fresh steps to relax rules for foreign investors. The announcement was made after the market closed on Tuesday. Support from its Asian peers which were mostly higher in morning trade after the Chinese central bank assured investors that it was committed to boosting growth and would infuse funds in the banking system, if necessary, also spurred investor sentiment.


The Nifty opened 19 points higher at 5,628 and the Sensex started the day at 18,662, a gain of 33 points over its previous close. Gains in oil & gas and IT stocks led the benchmarks to their highs in the first hour of trade. The Nifty rose to 5,635 and the Sensex inched up to 18,691 at their respective highs.


However, the benchmarks were range-bound fluctuating between the red and green in morning trade, a day ahead of the expiry of the F&O derivatives contract.


The market continued to see choppy trade and witnessed sideways movement in the noon session. However, reports of the rupee breaching the 60-mark against the dollar and touching a new all-time low of 60.35 in today, led the market into the red post-noon trade.


The decline led the market to its lows towards the end of the trading session. At the lows, the Nifty fell to 5,579 and the Sensex declined to 18,514.


The market finally settled near the lows of the day with the Nifty losing 20 points (0.36%) to 5,589 and the Sensex falling 77 points (0.41%) to settle at 18,552.


Among the broader indices, the BSE Mid-cap index declined 0.67% and the BSE Small-cap index fell 0.37%.


The gainers in the sectoral segment were BSE IT (up 1.69%); BSE Power (up 0.93%); BSE Fast Moving Consumer Goods (up 0.66%) and BSE TECk (up 0.40%). The main losers were BSE Auto (down 1.79%); BSE Metal (down 1.31%); BSE Consumer Durables, BSE Healthcare (down 1.12% each) and BSE Bankex (down 1.03%).


Out of the 30 stocks on the Sensex, 11 stocks settled higher. The gainers were Hero MotoCorp (up 3.45%); GAIL India (up .36%); TCS (up 2.84%); NTPC (up 2.13%) and Wipro (up .97%). The major losers were Bharti Airtel (down 5.74%); Mahindra & Mahindra (down 4.63%); Tata Motors (down 3.02%); Jindal Steel & Power (down 2.89%) and Hindalco Industries (down 2.32%).


The top two A Group gainers on the BSE were—Muthoot Finance (up 8.26%) and GlaxoSmithKline Consumer Healthcare (up 7.28%).

The top two A Group losers on the BSE were—Gitanjali Gems (down 9.99%) and Glenmark Pharmaceuticals (down 6.13%).


The top two B Group gainers on the BSE were—Cable Corporation of India (up 20%) and Caprihans India (up 20%).

The top two B Group losers on the BSE were—Indsil Hydro Power & Manganese (down 19.50%) and IOL Chemicals & Pharmaceuticals (down 16.67%).


Of the 50 stocks on the Nifty, 19 ended in the in the green. The major gainers were TCS (up 3.86%); Hero MotoCorp (up 3.84%); Asian Paints (up 3.82%); Power Grid Corporation (up 2.81%) and HCL Technologies (up 2.69%). The key losers were Bharti Airtel (down 5.91%); M&M (down 5.10%); Kotak Mahindra Bank (down 4.50%); IndusInd Bank (down 4.17%) and Ranbaxy Laboratories (down 3.66%).


Markets in Asia, with the exception of the Chinese and Japanese benchmarks, closed higher today after the People’s Bank of China asserted that it would take steps to ease liquidity crunch faced by the nation’s banks. The Nikkei 225 settled lower against the dollar.


The Hang Seng surged 2.43%; the Jakarta Composite surged 3.82%; the KLSE Composite gained 0.70%; the Straits Times advanced 0.47%; the Seoul Composite rose 0.16% and the Taiwan Weighted settled 1.59% higher. Among the losers, the Shanghai Composite fell 0.41% and the Nikkei 225 dropped 1.04%.


At the time of writing, key European markets were up between 1.08% and 1.84% on positive economic indicators from the US and Germany. At the same time, the US stock futures were trading in the green.


Back home, foreign institutional investors were net sellers of equities amounting to Rs1,285.86 crore on Tuesday. On the other hand, domestic institutional investors were net buyers of shares totalling Rs824.36 crore.


Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories has launched Lamotrigine Extended-Release (XR) tablets in the US market on 25th June. The move comes after the United States food and Drug Administration's approval to its abbreviated new drug application (ANDA). Lamotrigine XR is a therapeutic equivalent generic version of Lamictal XR (lamotrigine), which is indicated for the treatment of epilepsy. The stock fell 0.65% to close at Rs2,086.10 on the NSE.


Power equipment major Crompton Greaves today said it has bagged three orders worth over Rs231 crore from Power Grid Corporation of India. The contracts are for supplying equipment to state-run Power Grid for its Thiruvelum, Kurnool, Raipur and Wardha sub-stations. Crompton Greaves declined 3.49% to Rs78.70 on the NSE.


The United Nations-backed Medicines Patent Pool, Shilpa Medicare and Gilead Sciences have entered into an agreement to increase the access to medicines for HIV/AIDS treatment. The agreement covers tenofovir, emtricitabine, cobicistat, elvitegravir and a combination of the four known as “the Quad”, Medicines Patent Pool said. Shilpa Medicare gained 1.07% to close at RS255 on the NSE.


Reliance Capital ropes in Japan’s Sumitomo, Nippon for banking foray

Reliance Capital said that both Sumitomo and Nippon would have 4%-5% stake each in the proposed bank, subject to regulatory approvals

Readying itself for a bank licence, Anil Ambani-led group's Reliance Capital today said Japan’s Sumitomo Mitsui Bank and Nippon Life would become its strategic partners in the proposed banking venture, with each having 4%-5% stake.


Reliance Capital, which is present in a host of non-banking financial services businesses, would be the main promoter of the proposed bank, the application for which would be soon submitted to RBI, the company said in a statement.


Sumitomo Mitsui Trust Bank is one of the largest banks in Japan, while Nippon Life Insurance is among Asia’s largest financial services company and already has strategic stakes in Reliance Capital’s life insurance and mutual fund units.


With the latest move, Reliance Capital joins a host of other entities having firmed up their plans to seek a banking licence, for which applications need to be submitted by 1st July with the Reserve Bank of India (RBI).


There are reports that Tatas are also among the interested candidates, while Mahindras have dropped their plans to seek a bank licence.


Reliance Capital said that both Sumitomo and Nippon would have 4%-5% stake each in the proposed bank, subject to regulatory approvals, while agreements to this effect have been signed with them.


“Sumitomo Mitsui Trust Bank is amongst the largest banks in Japan and the largest institutional investor in the country,” Reliance Capital CEO Sam Ghosh said, while adding that it would bring in vast experience in retail and institutional banking to the new venture.


Sumitomo has total assets of $400 billion, advances of $238 billion and net assets of $25 billion.


Nippon Life, also known as Nissay, is Japan’s largest private life insurer with revenues of $71 billion, profits of $2 billion and it is also present in a host of other Asian countries and in North America and Europe.


Reliance Capital, the financial services arm of Anil Ambani-led business conglomerate Reliance Group, is present in insurance, mutual funds, brokerage, investment banking and a host of other financial services sectors.


Reliance Group also interests in telecom, power, infrastructure, media and entertainment, among others.


We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)